-
1
-
-
0027515373
-
Molecular characterization of a peripheral receptor for cannabinoids
-
Munro, S.; Thomas, K. L.; Abu-Shaar, M. Molecular characterization of a peripheral receptor for cannabinoids. Nature, 1993, 365, 61-65.
-
(1993)
Nature
, vol.365
, pp. 61-65
-
-
Munro, S.1
Thomas, K.L.2
Abu-Shaar, M.3
-
2
-
-
0035218154
-
Actions of cannabinoid receptor ligands on rat cultured sensory neurones: Implications for antinociception
-
Ross, R. A.; Coutts, A.A.; McFarlane, S.M.; Anavi-Goffer, S.; Irving, A.J.; Pertwee, R.G.; MacEwan D.J.; Scott, R.H. Actions of cannabinoid receptor ligands on rat cultured sensory neurones: implications for antinociception, Neuropharmacology,2001, 40, 221-232.
-
(2001)
Neuropharmacology
, vol.40
, pp. 221-232
-
-
Ross, R.A.1
Coutts, A.A.2
McFarlane, S.M.3
Anavi-Goffer, S.4
Irving, A.J.5
Pertwee, R.G.6
MacEwan, D.J.7
Scott, R.H.8
-
3
-
-
20044386244
-
Distribution of cannabinoid receptor 1 (CB1) and 2 (CB2) on sensory nerve fibers and adnexal structures in human skin
-
Ständer, S.; Schmelz, M.; Metze, D.; Luger T.; Rukwied, R. Distribution of cannabinoid receptor 1 (CB1) and 2 (CB2) on sensory nerve fibers and adnexal structures in human skin. J. Dermatol. Sci., 2005, 38, 177-188.
-
(2005)
J. Dermatol. Sci.
, vol.38
, pp. 177-188
-
-
Ständer, S.1
Schmelz, M.2
Metze, D.3
Luger, T.4
Rukwied, R.5
-
4
-
-
26844504226
-
Identification and functional characterization of brainstem cannabinoid CB2 receptors
-
Van Sickle, M. D.; Duncan, M.; Kingsley, P. J.; Mouihate, A.; Urbani, P.; Mackie, K.; Stella, N.; Makriyannis, A.; Piomelli, D.; Davison, J. S.; Marnett, L. J.; Di Marzo, V.; Pittman, Q. J.; Patel K. D.; Sharkey K. A. Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science, 2005, 310, 329-332.
-
(2005)
Science
, vol.310
, pp. 329-332
-
-
van Sickle, M.D.1
Duncan, M.2
Kingsley, P.J.3
Mouihate, A.4
Urbani, P.5
MacKie, K.6
Stella, N.7
Makriyannis, A.8
Piomelli, D.9
Davison, J.S.10
Marnett, L.J.11
Di Marzo, V.12
Pittman, Q.J.13
Patel, K.D.14
Sharkey, K.A.15
-
5
-
-
32844465920
-
Cannabinoid CB2 receptors: Immunhistochemical localization in rat brain
-
Gong, J. P.; Onaivi, E. S.; Ishiguro, H.; Liu, Q. R.; Tagliaferro, P. A.; Brusco A. Uhl, G. R. Cannabinoid CB2 receptors: immunhistochemical localization in rat brain. Brain Res., 2006, 1071, 10-23.
-
(2006)
Brain Res
, vol.1071
, pp. 10-23
-
-
Gong, J.P.1
Onaivi, E.S.2
Ishiguro, H.3
Liu, Q.R.4
Tagliaferro, P.A.5
Brusco, A.6
Uhl, G.R.7
-
6
-
-
33645106816
-
CB2 receptor-mediated antihyperalgesia: Possible direct involvement of neural mechanisms
-
Beltramo, M.; Bernardini, N.; Bertorelli, R.; Campanella, M.; Nicolussi, E.; Fredduzzi, S.; Reggiani, A. CB2 receptor-mediated antihyperalgesia: possible direct involvement of neural mechanisms. Eur. J. Neurosci., 2006, 23, 1530-1538.
-
(2006)
Eur. J. Neurosci.
, vol.23
, pp. 1530-1538
-
-
Beltramo, M.1
Bernardini, N.2
Bertorelli, R.3
Campanella, M.4
Nicolussi, E.5
Fredduzzi, S.6
Reggiani, A.7
-
7
-
-
68749110973
-
Functional CB2 type cannabinoid receptors at CNS synapses
-
Morgan, N. H.; Stanford, I. M.; Woodhall, G. L. Functional CB2 type cannabinoid receptors at CNS synapses. Neuropharmacology, 2009, 57, 356-368
-
(2009)
Neuropharmacology
, vol.57
, pp. 356-368
-
-
Morgan, N.H.1
Stanford, I.M.2
Woodhall, G.L.3
-
8
-
-
33846047809
-
Cerebral hypoxia-ischemia and middle cerebral artery occlusion induce expression of the cannabinoid CB2 receptor in the brain
-
Ashton, J. C.; Rahman, R. M.; Nair, S. M.; Sutherland, B.A.; Glass, M.; Appleton, I. Cerebral hypoxia-ischemia and middle cerebral artery occlusion induce expression of the cannabinoid CB2 receptor in the brain, Neurosci. Lett., 2007, 412, 114-117
-
(2007)
Neurosci. Lett.
, vol.412
, pp. 114-117
-
-
Ashton, J.C.1
Rahman, R.M.2
Nair, S.M.3
Sutherland, B.A.4
Glass, M.5
Appleton, I.6
-
9
-
-
33845959991
-
Cannabinoid CB2 receptor: A new target for the control of neural cell survival?
-
Fernández-Ruiz, J.; Romero, J.; Velasco, G.; Tolón, R. M.; Ramos, J. A.; Guzmán, M. Cannabinoid CB2 receptor: a new target for the control of neural cell survival? Trends Pharmacol. Sci., 2007, 28, 39-45.
-
(2007)
Trends Pharmacol. Sci.
, vol.28
, pp. 39-45
-
-
Fernández-Ruiz, J.1
Romero, J.2
Velasco, G.3
Tolón, R.M.4
Ramos, J.A.5
Guzmán, M.6
-
10
-
-
14944367009
-
A glial endogenous cannabinoid system is upregulated in the brains of macaques with simian immunodeficiency virus-induced encephalitis
-
Benito, C.; Kim, W. K.; Chavarria, I.; Hillard, C. J.; Mackie, K.; Tolon, R. M.; Williams K.; Romero, J. A glial endogenous cannabinoid system is upregulated in the brains of macaques with simian immunodeficiency virus-induced encephalitis, J. Neurosci., 2005, 25, 2530-2536.
-
(2005)
J. Neurosci.
, vol.25
, pp. 2530-2536
-
-
Benito, C.1
Kim, W.K.2
Chavarria, I.3
Hillard, C.J.4
MacKie, K.5
Tolon, R.M.6
Williams, K.7
Romero, J.8
-
11
-
-
37849049077
-
Glial expression of cannabinoid CB(2) receptors and fatty acid amide hydrolase are beta amyloid-linked events in Down's syndrome
-
Núñez, E.; Benito, C.; Tolón, R. M.; Hillard, C. J.; Griffin, W. S.; Romero, J. Glial expression of cannabinoid CB(2) receptors and fatty acid amide hydrolase are beta amyloid-linked events in Down's syndrome, Neuroscience, 2008, 151, 104-110.
-
(2008)
Neuroscience
, vol.151
, pp. 104-110
-
-
Núñez, E.1
Benito, C.2
Tolón, R.M.3
Hillard, C.J.4
Griffin, W.S.5
Romero, J.6
-
12
-
-
0348010292
-
Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaqueassociated glia in Alzheimer's disease brains
-
Benito, C.; Nuñez, E.; Tolón, R. M.; Carrier, E. J.; Rabano, A.; Hillard, C. J.; Romero, J. Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaqueassociated glia in Alzheimer's disease brains, J. Neurosci., 2003, 23, 11136-11141.
-
(2003)
J. Neurosci.
, vol.23
, pp. 11136-11141
-
-
Benito, C.1
Nuñez, E.2
Tolón, R.M.3
Carrier, E.J.4
Rabano, A.5
Hillard, C.J.6
Romero, J.7
-
13
-
-
33847420442
-
Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis
-
Benito, C.; Romero, J. P.; Tolón, R. M.; Clemente, D.; Docagne, F.; Hillard, C. J.; Guaza, Romero, J. Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis, J. Neurosci., 2007, 27, 2396-2402.
-
(2007)
J. Neurosci.
, vol.27
, pp. 2396-2402
-
-
Benito, C.1
Romero, J.P.2
Tolón, R.M.3
Clemente, D.4
Docagne, F.5
Hillard, C.J.6
Guaza7
Romero, J.8
-
14
-
-
33645224970
-
COX-2, CB2 and P2X7- immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord
-
Yiangou, Y.; Facer, P.; Durrenberger, P.; Chessell, I. P.; Naylor, A.; Bountra, C.; Banati, R. R.; Anand, P. COX-2, CB2 and P2X7- immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord. BMC Neurol., 2006, 6, 12.
-
(2006)
BMC Neurol
, vol.6
, pp. 12
-
-
Yiangou, Y.1
Facer, P.2
Durrenberger, P.3
Chessell, I.P.4
Naylor, A.5
Bountra, C.6
Banati, R.R.7
Anand, P.8
-
15
-
-
35649015179
-
The orphan receptor GPR55 is a novel cannabinoid receptor
-
Ryberg, E.; Larsson, N.; Sjögren, S.; Hjorth, S.; Hermansson, N. O.; Leonova, J.; Elebring, T.; Nilsson, K.; Drmota, T.; Greasley, P. J. The orphan receptor GPR55 is a novel cannabinoid receptor. Br. J. Pharmacol., 2007, 152, 1092-1101.
-
(2007)
Br. J. Pharmacol.
, vol.152
, pp. 1092-1101
-
-
Ryberg, E.1
Larsson, N.2
Sjögren, S.3
Hjorth, S.4
Hermansson, N.O.5
Leonova, J.6
Elebring, T.7
Nilsson, K.8
Drmota, T.9
Greasley, P.J.10
-
16
-
-
34548591720
-
Identification of GPR55 as a lysophosphatidylinositol receptor
-
Oka, S.; Nakajima, K.; Yamashita, A.; Kishimoto, S.; Sugiura, T. Identification of GPR55 as a lysophosphatidylinositol receptor. Biochem. Biophys. Res. Commun., 2007, 362, 928-934.
-
(2007)
Biochem. Biophys. Res. Commun.
, vol.362
, pp. 928-934
-
-
Oka, S.1
Nakajima, K.2
Yamashita, A.3
Kishimoto, S.4
Sugiura, T.5
-
17
-
-
58249109364
-
The GPR55 ligand L-alphalysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation
-
Henstridge, C. M.; Balenga, N. A.; Ford, L. A.; Ross, R. A.; Waldhoer, M.; Irving, A. J. The GPR55 ligand L-alphalysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation. FASEB J., 2009, 23, 183-193.
-
(2009)
FASEB J
, vol.23
, pp. 183-193
-
-
Henstridge, C.M.1
Balenga, N.A.2
Ford, L.A.3
Ross, R.A.4
Waldhoer, M.5
Irving, A.J.6
-
18
-
-
58149138962
-
2-Arachidonoyl-sn-glycero-3-phosphoinositol: A Possible Natural Ligand for GPR55
-
Oka, S.; Toshida, T.; Maruyama, K.; Nakajima, K.; Yamashita, A.; Sugiura, T. 2-Arachidonoyl-sn-glycero-3-phosphoinositol: A Possible Natural Ligand for GPR55. J. Biochem., 2009, 145, 13-20.
-
(2009)
J. Biochem.
, vol.145
, pp. 13-20
-
-
Oka, S.1
Toshida, T.2
Maruyama, K.3
Nakajima, K.4
Yamashita, A.5
Sugiura, T.6
-
19
-
-
0032586885
-
Gi protein modulation induced by a selective inverse agonist for the peripheral cannabinoid receptor CB2: Implication for intracellular signalization cross-regulation
-
Bouaboula, M.; Desnoyer, N.; Carayon, P.; Combes, T.; Casellas, P. Gi protein modulation induced by a selective inverse agonist for the peripheral cannabinoid receptor CB2: implication for intracellular signalization cross-regulation. Mol. Pharmacol., 1999, 55, 473-480.
-
(1999)
Mol. Pharmacol.
, vol.55
, pp. 473-480
-
-
Bouaboula, M.1
Desnoyer, N.2
Carayon, P.3
Combes, T.4
Casellas, P.5
-
20
-
-
33947259630
-
Inverse agonism: From curiosity to accepted dogma, but is it clinically relevant
-
Parra, S.; Bond, R. A. Inverse agonism: from curiosity to accepted dogma, but is it clinically relevant? Curr. Opin. Pharmacol., 2007, 7, 146-150.
-
(2007)
Curr. Opin. Pharmacol.
, vol.7
, pp. 146-150
-
-
Parra, S.1
Bond, R.A.2
-
21
-
-
1942487845
-
Recent advances in drug action and therapeutics: Relevance of novel concepts in G-protein-coupled receptor and signal transduction pharmacology
-
Brink, C. B.; Harvey, B. H.; Bodenstein, J.; Venter, D. P.; Oliver, D. W. Recent advances in drug action and therapeutics: Relevance of novel concepts in G-protein-coupled receptor and signal transduction pharmacology. Br. J. Clin. Pharmacol., 2004, 57, 373-387.
-
(2004)
Br. J. Clin. Pharmacol.
, vol.57
, pp. 373-387
-
-
Brink, C.B.1
Harvey, B.H.2
Bodenstein, J.3
Venter, D.P.4
Oliver, D.W.5
-
22
-
-
34247898951
-
The endocannabinoid system and rimonabant: A new drug with a novel mechanism of action involving cannabinoid CB1 receptor antagonism--or inverse agonism--as potential obesity treatment and other therapeutic use
-
Xie, S.; Furjanic, M. A.; Ferrara, J. J.; McAndrew, N. R.; Ardino, E. L.; Ngondara, A.; Bernstein, Y.; Thomas, K. J.; Kim, E.; Walker, J. M.; Nagar, S.; Ward, S. J.; Raffa, R. B. The endocannabinoid system and rimonabant: a new drug with a novel mechanism of action involving cannabinoid CB1 receptor antagonism--or inverse agonism--as potential obesity treatment and other therapeutic use. J. Clin. Pharm. Ther., 2007, 32, 209-231.
-
(2007)
J. Clin. Pharm. Ther.
, vol.32
, pp. 209-231
-
-
Xie, S.1
Furjanic, M.A.2
Ferrara, J.J.3
McAndrew, N.R.4
Ardino, E.L.5
Ngondara, A.6
Bernstein, Y.7
Thomas, K.J.8
Kim, E.9
Walker, J.M.10
Nagar, S.11
Ward, S.J.12
Raffa, R.B.13
-
23
-
-
57049102251
-
End of the line for cannabinoid receptor 1 as an antiobesity target? Nat
-
Jones, D. End of the line for cannabinoid receptor 1 as an antiobesity target? Nat. Rev. Drug Discov., 2008, 7, 961-962.
-
(2008)
Rev. Drug Discov.
, vol.7
, pp. 961-962
-
-
Jones, D.1
-
24
-
-
34248532300
-
Antiobesity efficacy of a novel cannabinoid-1 receptor inverse agonist, N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-[[5-(trifluoromethyl)pyridin-2-yl]oxy]propanamide (MK-0364), in rodents
-
Fong, T. M.; Guan, X. M.; Marsh, D. J.; Shen, C. P.; Stribling, D. S.; Rosko, K. M.; Lao, J.; Yu, H.; Feng, Y.; Xiao, J. C.; Van der Ploeg, L. H.; Goulet, M. T.; Hagmann, W. K.; Lin, L. S.; Lanza, T. J. Jr.; Jewell, J. P.; Liu, P.; Shah, S. K.; Qi, H.; Tong, X.; Wang, J.; Xu, S. S.; Francis, B.; Strack, A. M.; MacIntyre, D. E.; Shearman, L. P. Antiobesity efficacy of a novel cannabinoid-1 receptor inverse agonist, N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-[[5-(trifluoromethyl)pyridin-2-yl]oxy]propanamide (MK-0364), in rodents. J. Pharmacol. Exp. Ther., 2007, 321, 1013-1022.
-
(2007)
J. Pharmacol. Exp. Ther.
, vol.321
, pp. 1013-1022
-
-
Fong, T.M.1
Guan, X.M.2
Marsh, D.J.3
Shen, C.P.4
Stribling, D.S.5
Rosko, K.M.6
Lao, J.7
Yu, H.8
Feng, Y.9
Xiao, J.C.10
van der Ploeg, L.H.11
Goulet, M.T.12
Hagmann, W.K.13
Lin, L.S.14
Lanza Jr., T.J.15
Jewell, J.P.16
Liu, P.17
Shah, S.K.18
Qi, H.19
Tong, X.20
Wang, J.21
Xu, S.S.22
Francis, B.23
Strack, A.M.24
MacIntyre, D.E.25
Shearman, L.P.26
more..
-
25
-
-
65649122618
-
Cannabinoid receptor antagonists: Pharmacological opportunities, clinical experience, and translational prognosis
-
Janero, D. R.; Makriyannis, A. Cannabinoid receptor antagonists: pharmacological opportunities, clinical experience, and translational prognosis. Expert Opin. Emerg. Drugs, 2009, 14, 43-65.
-
(2009)
Expert Opin. Emerg. Drugs
, vol.14
, pp. 43-65
-
-
Janero, D.R.1
Makriyannis, A.2
-
26
-
-
40349101686
-
Recent advances in the development of selective ligands for the cannabinoid CB(2) receptor
-
Marriott, K. S.; Huffman, J. W. Recent advances in the development of selective ligands for the cannabinoid CB(2) receptor. Curr. Top. Med. Chem., 2008, 8, 187-204.
-
(2008)
Curr. Top. Med. Chem.
, vol.8
, pp. 187-204
-
-
Marriott, K.S.1
Huffman, J.W.2
-
27
-
-
62749123023
-
Cannabinoid type 2 receptor as a target for chronic pain
-
Beltramo, M. Cannabinoid type 2 receptor as a target for chronic pain. Mini Rev. Med. Chem., 2009, 9, 11-25.
-
(2009)
Mini Rev. Med. Chem.
, vol.9
, pp. 11-25
-
-
Beltramo, M.1
-
28
-
-
63049105150
-
Emerging role of the cannabinoid receptor CB2 in immune regulation: Therapeutic prospects for neuroinflammation
-
Cabral, G. A.; Griffin-Thomas, L. Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation. Expert Rev. Mol. Med., 2009, 11 (e3), 1-25
-
(2009)
Expert Rev. Mol. Med.
, vol.11
, Issue.e3
, pp. 1-25
-
-
Cabral, G.A.1
Griffin-Thomas, L.2
-
29
-
-
38349119137
-
Biology and therapeutic potential of cannabinoid CB2 receptor inverse agonists
-
Lunn, C. A.; Reich, E. P.; Fine, J. S.; Lavey, B.; Kozlowski, J. A.; Hipkin, R. W.; Lundell, D. J.; Bober, L. Biology and therapeutic potential of cannabinoid CB2 receptor inverse agonists. Br. J. Pharmacol., 2008, 153, 226-239.
-
(2008)
Br. J. Pharmacol.
, vol.153
, pp. 226-239
-
-
Lunn, C.A.1
Reich, E.P.2
Fine, J.S.3
Lavey, B.4
Kozlowski, J.A.5
Hipkin, R.W.6
Lundell, D.J.7
Bober, L.8
-
30
-
-
40349101686
-
Recent advances in the development of selective ligands for the cannabinoid CB(2) receptor
-
Marriott, K. S.; Huffman, J. W. Recent advances in the development of selective ligands for the cannabinoid CB(2) receptor. Curr. Top. Med. Chem., 2008, 8, 187-204.
-
(2008)
Curr. Top. Med. Chem.
, vol.8
, pp. 187-204
-
-
Marriott, K.S.1
Huffman, J.W.2
-
31
-
-
21044458324
-
Current knowledge on the antagonists and inverse agonists of cannabinoid receptors
-
Muccioli, G. G.; Lambert, D. M. Current knowledge on the antagonists and inverse agonists of cannabinoid receptors. Curr. Med. Chem., 2005, 12, 1361-1394.
-
(2005)
Curr. Med. Chem.
, vol.12
, pp. 1361-1394
-
-
Muccioli, G.G.1
Lambert, D.M.2
-
32
-
-
18444386531
-
Targeting the cannabinoid CB2 receptor: Mutations, modeling and development of CB2 selective ligands
-
Raitio, K. H.; Salo, O. M.; Nevalainen, T.; Poso, A.; Järvinen, T. Targeting the cannabinoid CB2 receptor: mutations, modeling and development of CB2 selective ligands. Curr. Med. Chem., 2005, 12, 1217-1237.
-
(2005)
Curr. Med. Chem.
, vol.12
, pp. 1217-1237
-
-
Raitio, K.H.1
Salo, O.M.2
Nevalainen, T.3
Poso, A.4
Järvinen, T.5
-
33
-
-
5644254040
-
Potent and selective antagonist of the CB2 cannabinoid receptor
-
Rinaldi-Carmona, M.; Barth, F.; Millan, J.; Derocq, J.-M.; Casellas, P.; Congy, C.; Oustric, D.; Sarran, M.; Bouaboula, M.; Calandra, B.; Portier, M.; Shire, D.; Brelière, J.-C.; Le Fur, G. Potent and selective antagonist of the CB2 cannabinoid receptor. J. Pharmacol. Exp. Ther., 1998, 284, 644-650.
-
(1998)
J. Pharmacol. Exp. Ther.
, vol.284
, pp. 644-650
-
-
Rinaldi-Carmona, M.1
Barth, F.2
Millan, J.3
Derocq, J.-M.4
Casellas, P.5
Congy, C.6
Oustric, D.7
Sarran, M.8
Bouaboula, M.9
Calandra, B.10
Portier, M.11
Shire, D.12
Brelière, J.-C.13
Le Fur, G.14
-
34
-
-
0033035659
-
SR 144528, an antagonist for the peripheral cannabinoid receptor that behaves as an inverse agonist
-
Portier, M.; Rinaldi-Carmona, M.; Pecceu, F.; Combes, T.; Poinot-Chazel, C.; Calandra, B.; Barth, F.; le Fur, G.; Casellas, P. SR 144528, an antagonist for the peripheral cannabinoid receptor that behaves as an inverse agonist. J. Pharmacol. Exp. Ther., 1999, 288, 582-589.
-
(1999)
J. Pharmacol. Exp. Ther.
, vol.288
, pp. 582-589
-
-
Portier, M.1
Rinaldi-Carmona, M.2
Pecceu, F.3
Combes, T.4
Poinot-Chazel, C.5
Calandra, B.6
Barth, F.7
Le Fur, G.8
Casellas, P.9
-
35
-
-
0035142746
-
In Vitro and in Vivo pharmacological characterization of JTE-907, a novel selective ligand for cannabinoid CB2 receptor
-
Iwamura, H.; Suzuki, H.; Ueda, Y.; Kaya, T.; Inaba, T. In Vitro and in Vivo pharmacological characterization of JTE-907, a novel selective ligand for cannabinoid CB2 receptor. J. Pharma. Exp. Ther., 2001, 296, 420-425.
-
(2001)
J. Pharma. Exp. Ther.
, vol.296
, pp. 420-425
-
-
Iwamura, H.1
Suzuki, H.2
Ueda, Y.3
Kaya, T.4
Inaba, T.5
-
36
-
-
33645423157
-
Synthesis and SAR studies of 2-oxoquinoline derivatives as CB2 receptor inverse agonists
-
Raitio, K. H.; Savinainen, J. R.; Vepsäläinen, J.; Laitinen, J. T.; Poso, A.; Järvinen, T.; Nevalainen, T. Synthesis and SAR studies of 2-oxoquinoline derivatives as CB2 receptor inverse agonists. J. Med. Chem., 2006, 49, 2022-2027.
-
(2006)
J. Med. Chem.
, vol.49
, pp. 2022-2027
-
-
Raitio, K.H.1
Savinainen, J.R.2
Vepsäläinen, J.3
Laitinen, J.T.4
Poso, A.5
Järvinen, T.6
Nevalainen, T.7
-
37
-
-
33845569474
-
Synthesis and in vitro evaluation of novel 2-oxo-1,2-dihydroquinoline CB2 receptor inverse agonists
-
Raitio, K. H.; Savinainen, J. R.; Nevalainen, T.; Järvinen, T.; Vepsäläinen, J. Synthesis and in vitro evaluation of novel 2-oxo-1,2-dihydroquinoline CB2 receptor inverse agonists. Chem. Biol. Drug Des., 2006, 68, 334-340.
-
(2006)
Chem. Biol. Drug Des.
, vol.68
, pp. 334-340
-
-
Raitio, K.H.1
Savinainen, J.R.2
Nevalainen, T.3
Järvinen, T.4
Vepsäläinen, J.5
-
38
-
-
50249127710
-
Design and synthesis of a novel series of N-alkyl isatin acylhydrazone derivatives that act as selective cannabinoid receptor 2 agonists for the treatment of neuropathic pain
-
Diaz, P.; Xu, J.; Astruc-Diaz, F.; Pan, H. M.; Brown, D. L.; Naguib, M. Design and synthesis of a novel series of N-alkyl isatin acylhydrazone derivatives that act as selective cannabinoid receptor 2 agonists for the treatment of neuropathic pain. J. Med. Chem., 2008, 51, 4932-4947.
-
(2008)
J. Med. Chem.
, vol.51
, pp. 4932-4947
-
-
Diaz, P.1
Xu, J.2
Astruc-Diaz, F.3
Pan, H.M.4
Brown, D.L.5
Naguib, M.6
-
39
-
-
60549101109
-
6-Methoxy-N-alkyl isatin acylhydrazone derivatives as a novel series of potent selective cannabinoid receptor 2 inverse agonists: Design, synthesis, and binding mode prediction
-
Diaz, P.; Phatak, S. S.; Xu, J.; Astruc-Diaz, F.; Cavasotto, C. N.; Naguib, M. 6-Methoxy-N-alkyl isatin acylhydrazone derivatives as a novel series of potent selective cannabinoid receptor 2 inverse agonists: design, synthesis, and binding mode prediction. J. Med. Chem., 2009, 52, 433-444.
-
(2009)
J. Med. Chem.
, vol.52
, pp. 433-444
-
-
Diaz, P.1
Phatak, S.S.2
Xu, J.3
Astruc-Diaz, F.4
Cavasotto, C.N.5
Naguib, M.6
-
40
-
-
33745622828
-
Novel benzimidazole derivatives as selective CB2 inverse agonists
-
Pagé, D.; Brochu, M.-C.; Yang, H.; Brown, W.; St-Onge, S.; Martin, E.; Salois, D. Novel benzimidazole derivatives as selective CB2 inverse agonists. Lett. Drug Des. Discov., 2006, 3, 298-303.
-
(2006)
Lett. Drug Des. Discov.
, vol.3
, pp. 298-303
-
-
Pagé, D.1
Brochu, M.-C.2
Yang, H.3
Brown, W.4
St-Onge, S.5
Martin, E.6
Salois, D.7
-
41
-
-
41849106134
-
5-Sulfonyl-benzimidazoles as selective CB2 agonists
-
Verbist, B. M.; De Cleyn, M. A.; Surkyn, M.; Fraiponts, E.; Aerssens, J.; Nijsen, M. J.; Gijsen, H. J. 5-Sulfonyl-benzimidazoles as selective CB2 agonists. Bioorg. Med. Chem. Lett., 2008, 18, 2574-2579.
-
(2008)
Bioorg. Med. Chem. Lett.
, vol.18
, pp. 2574-2579
-
-
Verbist, B.M.1
de Cleyn, M.A.2
Surkyn, M.3
Fraiponts, E.4
Aerssens, J.5
Nijsen, M.J.6
Gijsen, H.J.7
-
42
-
-
40149095112
-
Ligand-specific changes in M3 muscarinic acetylcholine receptor structure detected by a disulfide scanning strategy
-
Li, J. H.; Hamdan, F. F.; Kim, S. K.; Jacobson, K. A.; Zhang, X.; Han, S. J.; Wess, J. Ligand-specific changes in M3 muscarinic acetylcholine receptor structure detected by a disulfide scanning strategy. Biochemistry, 2008, 47, 2776-2788.
-
(2008)
Biochemistry
, vol.47
, pp. 2776-2788
-
-
Li, J.H.1
Hamdan, F.F.2
Kim, S.K.3
Jacobson, K.A.4
Zhang, X.5
Han, S.J.6
Wess, J.7
-
43
-
-
34447530948
-
Identification of an efficacy switch region in the ghrelin receptor responsible for interchange between agonis m and inverse agonism
-
Holst, B.; Mokrosinski, J.; Lang, M.; Brandt, E.; Nygaard, R.; Frimurer, T. M.; Beck-Sickinger, A. G.; Schwartz, T. W. Identification of an efficacy switch region in the ghrelin receptor responsible for interchange between agonis m and inverse agonism. J. Biol. Chem., 2007, 282, 15799-15811.
-
(2007)
J. Biol. Chem.
, vol.282
, pp. 15799-15811
-
-
Holst, B.1
Mokrosinski, J.2
Lang, M.3
Brandt, E.4
Nygaard, R.5
Frimurer, T.M.6
Beck-Sickinger, A.G.7
Schwartz, T.W.8
-
44
-
-
58849154165
-
Residues accessible in the binding-site crevice of transmembrane helix 6 of the CB2 cannabinoid receptor
-
Nebane, N. M.; Hurst, D. P.; Carrasquer, C. A.; Qiao, Z.; Reggio, P. H.; Song, Z.-H. Residues accessible in the binding-site crevice of transmembrane helix 6 of the CB2 cannabinoid receptor. Biochemistry, 2008, 47, 13811-13821.
-
(2008)
Biochemistry
, vol.47
, pp. 13811-13821
-
-
Nebane, N.M.1
Hurst, D.P.2
Carrasquer, C.A.3
Qiao, Z.4
Reggio, P.H.5
Song, Z.-H.6
-
45
-
-
22744435568
-
Identification of WIN55212-3 as a competitive neutral antagonist of the human cannabinoid CB2 receptor
-
Savinainen, J. R.; Kokkola, T.; Salo, O. M.; Poso, A.; Järvinen, T.; Laitinen, J. T. Identification of WIN55212-3 as a competitive neutral antagonist of the human cannabinoid CB2 receptor. Br. J. Pharmacol., 2005, 145, 636-645.
-
(2005)
Br. J. Pharmacol.
, vol.145
, pp. 636-645
-
-
Savinainen, J.R.1
Kokkola, T.2
Salo, O.M.3
Poso, A.4
Järvinen, T.5
Laitinen, J.T.6
-
46
-
-
60549116718
-
Discovery of novel CB2 receptor ligands by a pharmacophore-based virtual screening workflow
-
Markt, P.; Feldmann, C.; Rollinger, J. M.; Raduner, S.; Schuster D.; Kirchmair, J.; Distinto, S.; Spitzer, G. M.; Wolber, G.; Laggner, C.; Altmann, K. H.; Langer, T.; Gertsch, J. Discovery of novel CB2 receptor ligands by a pharmacophore-based virtual screening workflow. J. Med. Chem., 2009, 52, 369-378.
-
(2009)
J. Med. Chem.
, vol.52
, pp. 369-378
-
-
Markt, P.1
Feldmann, C.2
Rollinger, J.M.3
Raduner, S.4
Schuster, D.5
Kirchmair, J.6
Distinto, S.7
Spitzer, G.M.8
Wolber, G.9
Laggner, C.10
Altmann, K.H.11
Langer, T.12
Gertsch, J.13
-
47
-
-
56049101882
-
Ligand-binding architecture of human CB2 cannabinoid receptor: Evidence for receptor subtype-specific binding motif and modeling GPCR activation
-
Pei Y.; Mercier, R. W.; Anday, J. K.; Thakur, G. A.; Zvonok, A. M.; Hurst, D.; Reggio, P. H.; Janero, D. R.; Makriyannis, A. Ligand-binding architecture of human CB2 cannabinoid receptor: evidence for receptor subtype-specific binding motif and modeling GPCR activation. Chem. Biol., 2008, 15, 1207-1219.
-
(2008)
Chem. Biol.
, vol.15
, pp. 1207-1219
-
-
Pei, Y.1
Mercier, R.W.2
Anday, J.K.3
Thakur, G.A.4
Zvonok, A.M.5
Hurst, D.6
Reggio, P.H.7
Janero, D.R.8
Makriyannis, A.9
-
48
-
-
65549091123
-
Structural biology of human cannabinoid receptor-2 helix 6 in membrane-mimetic environments
-
Tiburu, E. K.; Tyukhtenko, S.; Deshmukh, L.; Vinogradova, O.; Janero, D. R.; Makriyannis, A. Structural biology of human cannabinoid receptor-2 helix 6 in membrane-mimetic environments. Biochem. Biophys. Res. Commun., 2009, 384, 243-248.
-
(2009)
Biochem. Biophys. Res. Commun.
, vol.384
, pp. 243-248
-
-
Tiburu, E.K.1
Tyukhtenko, S.2
Deshmukh, L.3
Vinogradova, O.4
Janero, D.R.5
Makriyannis, A.6
-
49
-
-
33748490903
-
In vitro pharmacological characterization of AM1241: A protean agonist at the cannabinoid CB2 receptor?
-
Yao, B. B.; Mukherjee, S.; Fan, Y.; Garrison, T. R.; Daza, A. V.; Grayson, G. K.; Hooker, B. A.; Dart, M. J.; Sullivan, J. P.; Meyer, M. D. In vitro pharmacological characterization of AM1241: a protean agonist at the cannabinoid CB2 receptor? Br. J. Pharmacol., 2006, 149, 145-54.
-
(2006)
Br. J. Pharmacol.
, vol.149
, pp. 145-154
-
-
Yao, B.B.1
Mukherjee, S.2
Fan, Y.3
Garrison, T.R.4
Daza, A.V.5
Grayson, G.K.6
Hooker, B.A.7
Dart, M.J.8
Sullivan, J.P.9
Meyer, M.D.10
-
50
-
-
34547578961
-
Species-specific in vitro pharmacological effects of the cannabinoid receptor 2 (CB2) selective ligand AM1241 and its resolved enantiomers
-
Bingham, B.; Jones, P. G.; Uveges, A. J.; Kotnis, S.; Lu, P.; Smith, V. A.; Sun, S.-C,; Resnick, L.; Chlenov, M.; He, Y.; Strassle, B. W.; Cummons, T. A.; Piesla, M. J.; Harrison, J. E.; Whiteside, G. T.; Kennedy, J. D. Species-specific in vitro pharmacological effects of the cannabinoid receptor 2 (CB2) selective ligand AM1241 and its resolved enantiomers. Br. J. Pharmacol., 2007, 151, 1061-1070.
-
(2007)
Br. J. Pharmacol.
, vol.151
, pp. 1061-1070
-
-
Bingham, B.1
Jones, P.G.2
Uveges, A.J.3
Kotnis, S.4
Lu, P.5
Smith, V.A.6
Sun, S.-C.7
Resnick, L.8
Chlenov, M.9
He, Y.10
Strassle, B.W.11
Cummons, T.A.12
Piesla, M.J.13
Harrison, J.E.14
Whiteside, G.T.15
Kennedy, J.D.16
-
51
-
-
69249230885
-
Constitutive activity of cannabinoid-2 (CB) receptors plays an essential role in the protean agonism of (+)AM1241 and L768242
-
Mancini, I.; Brusa, R.; Quadrato, G.; Foglia, C.; Scandroglio, P.; Silverman, L.; Tulshian, D.; Reggiani, A.; Beltramo, M. Constitutive activity of cannabinoid-2 (CB) receptors plays an essential role in the protean agonism of (+)AM1241 and L768242. Br. J. Pharmacol., 2009, 158, 382-391
-
(2009)
Br. J. Pharmacol.
, vol.158
, pp. 382-391
-
-
Mancini, I.1
Brusa, R.2
Quadrato, G.3
Foglia, C.4
Scandroglio, P.5
Silverman, L.6
Tulshian, D.7
Reggiani, A.8
Beltramo, M.9
-
52
-
-
0030840923
-
Protean agonists. Keys to receptor active states?
-
Kenakin, T. Protean agonists. Keys to receptor active states? Ann. N. Y. Acad. Sci., 1997, 812, 116-125.
-
(1997)
Ann. N. Y. Acad. Sci.
, vol.812
, pp. 116-125
-
-
Kenakin, T.1
-
53
-
-
0141702358
-
Protean agonism at histamine H3 receptors in vitro and in vivo
-
Gbahou, F.; Rouleau, A.; Morisset, S.; Parmentier, R.; Crochet, S.; Lin, J. S.; Ligneau, X.; Tardivel-Lacombe, J.; Stark, H.; Schunack, W.; Ganellin, C. R.; Schwartz, J. C.; Arrang, J. M. Protean agonism at histamine H3 receptors in vitro and in vivo. Proc. Natl. Acad. Sci. USA, 2003, 100, 11086-11091.
-
(2003)
Proc. Natl. Acad. Sci. USA
, vol.100
, pp. 11086-11091
-
-
Gbahou, F.1
Rouleau, A.2
Morisset, S.3
Parmentier, R.4
Crochet, S.5
Lin, J.S.6
Ligneau, X.7
Tardivel-Lacombe, J.8
Stark, H.9
Schunack, W.10
Ganellin, C.R.11
Schwartz, J.C.12
Arrang, J.M.13
-
54
-
-
0032410647
-
Protean effects of a natural peptide agonist of the G protein-coupled secretin receptor demonstrated by receptor mutagenesis
-
Ganguli, S. C.; Park, C. G.; Holtmann, M. H.; Hadac, E. M.; Kenakin, T. P.; Miller, L. J. Protean effects of a natural peptide agonist of the G protein-coupled secretin receptor demonstrated by receptor mutagenesis. J. Pharmacol. Exp. Ther., 1998, 286, 593-598.
-
(1998)
J. Pharmacol. Exp. Ther.
, vol.286
, pp. 593-598
-
-
Ganguli, S.C.1
Park, C.G.2
Holtmann, M.H.3
Hadac, E.M.4
Kenakin, T.P.5
Miller, L.J.6
-
55
-
-
0031596989
-
Protean agonism at alpha2A-adrenoceptors
-
Jansson, C. C.; Kukkonen, J. P.; Näsman, J.; Huifang, G.; Wurster, S.; Virtanen, R.; Savola, J. M.; Cockcroft, V.; Akerman, K. E. Protean agonism at alpha2A-adrenoceptors. Mol. Pharmacol., 1998, 53, 963-968.
-
(1998)
Mol. Pharmacol.
, vol.53
, pp. 963-968
-
-
Jansson, C.C.1
Kukkonen, J.P.2
Näsman, J.3
Huifang, G.4
Wurster, S.5
Virtanen, R.6
Savola, J.M.7
Cockcroft, V.8
Akerman, K.E.9
-
56
-
-
0038137537
-
Dissimilar pharmacological responses by a new series of imidazoline derivatives at precoupled and ligand-activated alpha 2A-adrenoceptor states: Evidence for effector pathway-dependent differential antagonism
-
Pauwels, P. J.; Rauly, I.; Wurch, T. Dissimilar pharmacological responses by a new series of imidazoline derivatives at precoupled and ligand-activated alpha 2A-adrenoceptor states: evidence for effector pathway-dependent differential antagonism. J. Pharmacol. Exp. Ther., 2003, 305, 1015-1023.
-
(2003)
J. Pharmacol. Exp. Ther.
, vol.305
, pp. 1015-1023
-
-
Pauwels, P.J.1
Rauly, I.2
Wurch, T.3
-
57
-
-
34250181382
-
Optimization of triaryl bis-sulfones as cannabinoid-2 receptor ligands
-
Lavey, B. J.; Kozlowski, J. A.; Shankar, B. B.; Spitler, J. M.; Zhou, G.; Yang, D. Y.; Shu, Y.; Wong, M. K.; Wong, S. C.; Shih, N. Y.; Wu, J.; McCombie, S. W.; Rizvi, R.; Wolin, R. L.; Lunn, C. A. Optimization of triaryl bis-sulfones as cannabinoid-2 receptor ligands. Bioorg. Med. Chem. Lett., 2007, 17, 3760-3764.
-
(2007)
Bioorg. Med. Chem. Lett.
, vol.17
, pp. 3760-3764
-
-
Lavey, B.J.1
Kozlowski, J.A.2
Shankar, B.B.3
Spitler, J.M.4
Zhou, G.5
Yang, D.Y.6
Shu, Y.7
Wong, M.K.8
Wong, S.C.9
Shih, N.Y.10
Wu, J.11
McCombie, S.W.12
Rizvi, R.13
Wolin, R.L.14
Lunn, C.A.15
-
58
-
-
61349200341
-
Design and synthesis of novel tri-aryl CB2 selective cannabinoid ligands
-
Bhattacharjee, H.; Gurley, S. N., Moore II, B. M. Design and synthesis of novel tri-aryl CB2 selective cannabinoid ligands. Bioorg. Med. Chem. Lett., 2009, 19, 1691-1693.
-
(2009)
Bioorg. Med. Chem. Lett.
, vol.19
, pp. 1691-1693
-
-
Bhattacharjee, H.1
Gurley, S.N.2
Moore II, B.M.3
-
59
-
-
34447342817
-
Himbacine derived thrombin receptor (PAR-1) antagonists: SAR of the pyridine ring
-
Xia, Y.; Chackalamannil, S.; Clasby, M.; Doller, D.; Eagen, K.; Greenlee, W. J,; Tsai, H., Agans-Fantuzzi, J.; Ahn, H. S.; Boykow, G. C,; Hsieh, Y.; Lunn, C. A.; Chintala, M. Himbacine derived thrombin receptor (PAR-1) antagonists: SAR of the pyridine ring. Bioorg. Med. Chem. Lett., 2007, 17, 4509-4913.
-
(2007)
Bioorg. Med. Chem. Lett.
, vol.17
, pp. 4509-4913
-
-
Xia, Y.1
Chackalamannil, S.2
Clasby, M.3
Doller, D.4
Eagen, K.5
Greenlee, W.J.6
Tsai, H.7
Agans-Fantuzzi, J.8
Ahn, H.S.9
Boykow, G.C.10
Hsieh, Y.11
Lunn, C.A.12
Chintala, M.13
-
60
-
-
55749113512
-
Reciprocal influences of CB1 cannabinoid receptor agonists on ERK and JNK signalling in N1E-115 cells
-
Bosier, B.; Lambert, D. M.; Hermans, E. Reciprocal influences of CB1 cannabinoid receptor agonists on ERK and JNK signalling in N1E-115 cells. FEBS Lett., 2008, 582, 3861-3867.
-
(2008)
FEBS Lett
, vol.582
, pp. 3861-3867
-
-
Bosier, B.1
Lambert, D.M.2
Hermans, E.3
-
61
-
-
57249103358
-
Concomitant activation of adenylyl cyclase suppresses the opposite influences of CB(1) cannabinoid receptor agonists on tyrosine hydroxylase expression
-
Bosier, B.; Hermans, E.; Lambert, D. M. Concomitant activation of adenylyl cyclase suppresses the opposite influences of CB(1) cannabinoid receptor agonists on tyrosine hydroxylase expression. Biochem. Pharmacol., 2009, 77, 216-227.
-
(2009)
Biochem. Pharmacol.
, vol.77
, pp. 216-227
-
-
Bosier, B.1
Hermans, E.2
Lambert, D.M.3
-
62
-
-
0032756226
-
Agonist selective regulation of G proteins by cannabinoid CB(1) and CB(2) receptors
-
Glass, M.; Northup, J. K. Agonist selective regulation of G proteins by cannabinoid CB(1) and CB(2) receptors. Mol. Pharmacol., 1999, 56, 1362-1369.
-
(1999)
Mol. Pharmacol.
, vol.56
, pp. 1362-1369
-
-
Glass, M.1
Northup, J.K.2
-
63
-
-
54249137719
-
Differential coupling of the human cannabinoid receptors hCB1R and hCB2R to the G-protein G(alpha)i2beta1gamma2
-
Nickl, K.; Gardner, E. E.; Geiger, S.; Heilmann, J.; Seifert, R. Differential coupling of the human cannabinoid receptors hCB1R and hCB2R to the G-protein G(alpha)i2beta1gamma2. Neurosci. Lett., 2008, 447, 68-72.
-
(2008)
Neurosci. Lett.
, vol.447
, pp. 68-72
-
-
Nickl, K.1
Gardner, E.E.2
Geiger, S.3
Heilmann, J.4
Seifert, R.5
-
64
-
-
0038540318
-
Biochemical and pharmacological control of the multiplicity of coupling at G-protein-coupled receptors
-
Hermans, E. Biochemical and pharmacological control of the multiplicity of coupling at G-protein-coupled receptors. Pharmacol. Ther., 2003, 99, 25-44.
-
(2003)
Pharmacol. Ther.
, vol.99
, pp. 25-44
-
-
Hermans, E.1
-
65
-
-
63849235865
-
Evaluating cellular impedance assays for detection of GPCR pleiotropic signaling and functional selectivity
-
Peters, M. F.; Scott, C. W. Evaluating cellular impedance assays for detection of GPCR pleiotropic signaling and functional selectivity. J. Biomol. Screen., 2009, 14, 246-255.
-
(2009)
J. Biomol. Screen.
, vol.14
, pp. 246-255
-
-
Peters, M.F.1
Scott, C.W.2
-
66
-
-
58249122333
-
Characterization of human cannabinoid CB2 receptor coupled to chimeric Galpha(qi5) and Galpha(qo5) proteins
-
Malysz, J.; Daza, A. V.; Kage, K.; Grayson, G. K.; Yao, B. B.; Meyer, M. D.; Gopalakrishnan, M. Characterization of human cannabinoid CB2 receptor coupled to chimeric Galpha(qi5) and Galpha(qo5) proteins. Eur. J. Pharmacol., 2009, 603, 12-21.
-
(2009)
Eur. J. Pharmacol.
, vol.603
, pp. 12-21
-
-
Malysz, J.1
Daza, A.V.2
Kage, K.3
Grayson, G.K.4
Yao, B.B.5
Meyer, M.D.6
Gopalakrishnan, M.7
-
67
-
-
41949089470
-
Beta-arrestin-biased agonism at the beta2- adrenergic receptor
-
Drake, M. T.; Violin, J. D.; Whalen, E. J.; Wisler, J. W.; Shenoy, S. K.; Lefkowitz, R. J. beta-arrestin-biased agonism at the beta2- adrenergic receptor. J. Biol. Chem., 2008, 283, 5669-5676.
-
(2008)
J. Biol. Chem.
, vol.283
, pp. 5669-5676
-
-
Drake, M.T.1
Violin, J.D.2
Whalen, E.J.3
Wisler, J.W.4
Shenoy, S.K.5
Lefkowitz, R.J.6
-
68
-
-
42749095676
-
Translocation of arrestin induced by human A3 adenosine receptor ligands in an engineered cell line: Comparison with G protein-dependent pathways
-
Gao, Z.-G.; Jacobson, K. A. Translocation of arrestin induced by human A3 adenosine receptor ligands in an engineered cell line: Comparison with G protein-dependent pathways. Pharmacol. Res., 2008, 57, 303-311.
-
(2008)
Pharmacol. Res.
, vol.57
, pp. 303-311
-
-
Gao, Z.-G.1
Jacobson, K.A.2
-
69
-
-
37649023273
-
A beta-arrestin 2 signaling complex mediates lithium action on behavior
-
Beaulieu, J. M.; Marion, S.; Rodriguiz, R. M.; Medvedev, I. O.; Sotnikova, T. D.; Ghisi, V.; Wetsel, W. C.; Lefkowitz, R. J.; Gainetdinov, R. R.; Caron, M. G. A beta-arrestin 2 signaling complex mediates lithium action on behavior. Cell, 2008, 132, 125-136.
-
(2008)
Cell
, vol.132
, pp. 125-136
-
-
Beaulieu, J.M.1
Marion, S.2
Rodriguiz, R.M.3
Medvedev, I.O.4
Sotnikova, T.D.5
Ghisi, V.6
Wetsel, W.C.7
Lefkowitz, R.J.8
Gainetdinov, R.R.9
Caron, M.G.10
-
70
-
-
33751533776
-
New roles for betaarrestins in cell signaling: Not just for seven-transmembrane receptors
-
Lefkowitz, R. J.; Rajagopal, K.; Whalen, E. J. New roles for betaarrestins in cell signaling: not just for seven-transmembrane receptors. Mol. Cell, 2006, 24, 643-652.
-
(2006)
Mol. Cell
, vol.24
, pp. 643-652
-
-
Lefkowitz, R.J.1
Rajagopal, K.2
Whalen, E.J.3
-
71
-
-
0141483377
-
A beta-arrestindependent scaffold is associated with prolonged MAPK activation in pseudopodia during protease-activated receptor-2-induced chemotaxis
-
Ge, L.; Ly, Y.; Hollenberg, M.; DeFea, K. A beta-arrestindependent scaffold is associated with prolonged MAPK activation in pseudopodia during protease-activated receptor-2-induced chemotaxis. J. Biol. Chem., 2003, 278, 34418-34426.
-
(2003)
J. Biol. Chem.
, vol.278
, pp. 34418-34426
-
-
Ge, L.1
Ly, Y.2
Hollenberg, M.3
Defea, K.4
-
72
-
-
33646263875
-
Cooperative regulation of extracellular signal-regulated kinase activation and cell shape change by filamin A and beta-arrestins
-
Scott, M. G.; Pierotti, V.; Storez, H.; Lindberg, E.; Thuret, A.; Muntaner, O.; Labbe-Jullie, C.; Pitcher, J. A.; Marullo, S.; Cooperative regulation of extracellular signal-regulated kinase activation and cell shape change by filamin A and beta-arrestins. Mol. Cell. Biol., 2006, 26, 3432-3445.
-
(2006)
Mol. Cell. Biol.
, vol.26
, pp. 3432-3445
-
-
Scott, M.G.1
Pierotti, V.2
Storez, H.3
Lindberg, E.4
Thuret, A.5
Muntaner, O.6
Labbe-Jullie, C.7
Pitcher, J.A.8
Marullo, S.9
-
73
-
-
0141608603
-
Beta-arrestin-2 regulates the development of allergic asthma
-
Walker, J. K.; Fong, A. M.; Lawson, B. L.; Savov, J. D.; Patel D. D.; Schwartz, D. A., Lefkowitz, R. J: Beta-arrestin-2 regulates the development of allergic asthma. J. Clin. Invest., 2003, 112, 566-574.
-
(2003)
J. Clin. Invest.
, vol.112
, pp. 566-574
-
-
Walker, J.K.1
Fong, A.M.2
Lawson, B.L.3
Savov, J.D.4
Patel, D.D.5
Schwartz, D.A.6
Lefkowitz, R.J.7
-
74
-
-
31144468211
-
A novel cannabinoid peripheral cannabinoid receptorselective inverse agonist blocks leukocyte recruitment in Vivo
-
Lunn, C. A.; Fine, J.; Rojas-Triana, A.; Jackson, J. V.; Fan, X.; Kung, T. T.; Gonsiorek, W.; Schwarz, M. A.; Lavey, B.; Kozlowski, J. A.; Narula, S. K.; Lundell, D. J.; Hipkin, R. W.; Bober, L. A novel cannabinoid peripheral cannabinoid receptorselective inverse agonist blocks leukocyte recruitment in Vivo. J. Pharma. Exp. Ther., 2006, 316, 780-788.
-
(2006)
J. Pharma. Exp. Ther.
, vol.316
, pp. 780-788
-
-
Lunn, C.A.1
Fine, J.2
Rojas-Triana, A.3
Jackson, J.V.4
Fan, X.5
Kung, T.T.6
Gonsiorek, W.7
Schwarz, M.A.8
Lavey, B.9
Kozlowski, J.A.10
Narula, S.K.11
Lundell, D.J.12
Hipkin, R.W.13
Bober, L.14
-
75
-
-
58849083281
-
Characterizing cannabinoid CB2 receptor ligands using discoveRx pathHunterTM {beta}-arrestin assay
-
McGuinness, D.; Malikzay, A.; Visconti, R.; Lin, K.; Bayne, M.; Monsma, F.; Lunn, C. A. Characterizing cannabinoid CB2 receptor ligands using discoveRx pathHunterTM {beta}-arrestin assay. J. Biomol. Screen., 2009, 14, 49-58.
-
(2009)
J. Biomol. Screen.
, vol.14
, pp. 49-58
-
-
McGuinness, D.1
Malikzay, A.2
Visconti, R.3
Lin, K.4
Bayne, M.5
Monsma, F.6
Lunn, C.A.7
-
76
-
-
56649122099
-
Mu- Opioid receptor forms a functional heterodimer with cannabinoid CB1 receptor: Electrophysiological and FRET assay analysis
-
Hojo, M.; Sudo, Y.; Ando, Y.; Minami, K.; Takada, M.; Matsubara, T.; Kanaide, M.; Taniyama, K.; Sumikawa, K.; Uezono, Y. mu- Opioid receptor forms a functional heterodimer with cannabinoid CB1 receptor: electrophysiological and FRET assay analysis. J. Pharmacol. Sci., 2008, 108, 308-319.
-
(2008)
J. Pharmacol. Sci.
, vol.108
, pp. 308-319
-
-
Hojo, M.1
Sudo, Y.2
Ando, Y.3
Minami, K.4
Takada, M.5
Matsubara, T.6
Kanaide, M.7
Taniyama, K.8
Sumikawa, K.9
Uezono, Y.10
-
77
-
-
17844410926
-
Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors enhances heterodimer formation: A mechanism for receptor cross-talk?
-
Kearn, C. S.; Blake-Palmer, K.; Daniel, E.; Mackie, K.; Glass, M. Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors enhances heterodimer formation: a mechanism for receptor cross-talk? Mol. Pharmacol., 2005, 67, 1697-1704.
-
(2005)
Mol. Pharmacol.
, vol.67
, pp. 1697-1704
-
-
Kearn, C.S.1
Blake-Palmer, K.2
Daniel, E.3
MacKie, K.4
Glass, M.5
-
78
-
-
33846030175
-
Orexin-1 receptor-cannabinoid CB1 receptor heterodimerization results in both ligand-dependent and -independent coordinated alterations of receptor localization and function
-
Ellis, J.; Pediani, J. D.; Canals, M.; Milasta, S.; Milligan, G. Orexin-1 receptor-cannabinoid CB1 receptor heterodimerization results in both ligand-dependent and -independent coordinated alterations of receptor localization and function. J. Biol. Chem., 2006, 281, 38812-38824.
-
(2006)
J. Biol. Chem.
, vol.281
, pp. 38812-38824
-
-
Ellis, J.1
Pediani, J.D.2
Canals, M.3
Milasta, S.4
Milligan, G.5
-
79
-
-
43449130045
-
The cannabinoid delta-9-tetrahydrocannabinol mediates inhibition of macrophage chemotaxis to RANTES/CCL5: Linkage to the CB2 receptor
-
Raborn, E. S.; Marciano-Cabral, F.; Buckley, N. E.; Martin, B. R.; Cabral, G. A. The cannabinoid delta-9-tetrahydrocannabinol mediates inhibition of macrophage chemotaxis to RANTES/CCL5: linkage to the CB2 receptor. J. Neuroimmune Pharmacol., 2008, 3, 117-129
-
(2008)
J. Neuroimmune Pharmacol.
, vol.3
, pp. 117-129
-
-
Raborn, E.S.1
Marciano-Cabral, F.2
Buckley, N.E.3
Martin, B.R.4
Cabral, G.A.5
-
80
-
-
52049093883
-
Endocannabinoids as positive or negative factors in hematopoietic cell migration and differentiation
-
Patinkin, D.; Milman, G.; Breuer, A.; Fride, E.; Mechoulam, R. Endocannabinoids as positive or negative factors in hematopoietic cell migration and differentiation. Eur. J. Pharmacol., 2008, 595, 1-6.
-
(2008)
Eur. J. Pharmacol.
, vol.595
, pp. 1-6
-
-
Patinkin, D.1
Milman, G.2
Breuer, A.3
Fride, E.4
Mechoulam, R.5
-
81
-
-
35448940523
-
Induction of preferential chemotaxis of unstimulated B-lymphocytes by 2-arachidonoylglycerol in immunized mice
-
Tanikawa, T.; Kurohane, K.; Imai, Y. Induction of preferential chemotaxis of unstimulated B-lymphocytes by 2-arachidonoylglycerol in immunized mice. Microbiol. Immunol., 2007, 51, 1013-1019.
-
(2007)
Microbiol. Immunol.
, vol.51
, pp. 1013-1019
-
-
Tanikawa, T.1
Kurohane, K.2
Imai, Y.3
-
82
-
-
39849087246
-
Expression and function of cannabinoid receptors CB1 and CB2 and their cognate cannabinoid ligands in murine embryonic stem cells
-
doi: 10.1371/ journal.pone.0000641
-
Jiang, S.; Fu, Y.; Williams, J.; Wood, J.; Pandarinathan, L.; Avraham, S.; Makriyannis, A.; Avraham, S.; Avraham, H. K. Expression and function of cannabinoid receptors CB1 and CB2 and their cognate cannabinoid ligands in murine embryonic stem cells. PLoS ONE, 2007, 2, e641, doi: 10.1371/ journal.pone.0000641.
-
(2007)
PLoS ONE
, vol.2
-
-
Jiang, S.1
Fu, Y.2
Williams, J.3
Wood, J.4
Pandarinathan, L.5
Avraham, S.6
Makriyannis, A.7
Avraham, S.8
Avraham, H.K.9
-
83
-
-
33745065869
-
Chemotaxis of human peripheral blood eosinophils to 2-arachidonoylglycerol: Comparison with other eosinophil chemoattractants
-
Kishimoto, S.; Oka, S.; Gokoh, M.; Sugiura, T. Chemotaxis of human peripheral blood eosinophils to 2-arachidonoylglycerol: comparison with other eosinophil chemoattractants. Int. Arch. Allergy Immunol., 2006, 140, 3-7.
-
(2006)
Int. Arch. Allergy Immunol.
, vol.140
, pp. 3-7
-
-
Kishimoto, S.1
Oka, S.2
Gokoh, M.3
Sugiura, T.4
-
84
-
-
41549162387
-
CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathways
-
Montecucco, F.; Burger, F.; Mach, F.; Steffens, S. CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathways. Am. J. Physiol. Heart Circ. Physiol., 2008, 294, H1145-55.
-
(2008)
Am. J. Physiol. Heart Circ. Physiol.
, vol.294
-
-
Montecucco, F.1
Burger, F.2
Mach, F.3
Steffens, S.4
-
85
-
-
38549130466
-
Inhibition of human neutrophil chemotaxis by endogenous cannabinoids and phytocannabinoids: Evidence for a site distinct from CB1 and CB2
-
McHugh, D.; Tanner, C.; Mechoulam, R.; Pertwee, R. G.; Ross, R. A. Inhibition of human neutrophil chemotaxis by endogenous cannabinoids and phytocannabinoids: evidence for a site distinct from CB1 and CB2. Mol. Pharmacol., 2008, 73, 441-450.
-
(2008)
Mol. Pharmacol.
, vol.73
, pp. 441-450
-
-
McHugh, D.1
Tanner, C.2
Mechoulam, R.3
Pertwee, R.G.4
Ross, R.A.5
-
86
-
-
35348946336
-
CB2-receptor stimulation attenuates TNF-alphainduced human endothelial cell activation, transendothelial migration of monocytes, and monocyte-endothelial adhesion
-
Rajesh, M.; Mukhopadhyay, P.; Bátkai, S.; Haskó, G.; Liaudet, L.; Huffman, J. W.; Csiszar, A.; Ungvari, Z.; Mackie, K.; Chatterjee, S.; Pacher, P. CB2-receptor stimulation attenuates TNF-alphainduced human endothelial cell activation, transendothelial migration of monocytes, and monocyte-endothelial adhesion. Am. J. Physiol. Heart Circ. Physiol., 2007, 293, H2210-H2218.
-
(2007)
Am. J. Physiol. Heart Circ. Physiol.
, vol.293
-
-
Rajesh, M.1
Mukhopadhyay, P.2
Bátkai, S.3
Haskó, G.4
Liaudet, L.5
Huffman, J.W.6
Csiszar, A.7
Ungvari, Z.8
MacKie, K.9
Chatterjee, S.10
Pacher, P.11
-
87
-
-
33846583671
-
Temporal variation in CB2R levels following T lymphocyte activation: Evidence that cannabinoids modulate CXCL12-induced chemotaxis
-
Coopman, K.; Smith, L. D.; Wright, K. L.; Ward, S. G. Temporal variation in CB2R levels following T lymphocyte activation: evidence that cannabinoids modulate CXCL12-induced chemotaxis. Int. Immunopharmacol., 2007, 7, 360-371.
-
(2007)
Int. Immunopharmacol.
, vol.7
, pp. 360-371
-
-
Coopman, K.1
Smith, L.D.2
Wright, K.L.3
Ward, S.G.4
-
88
-
-
34548446421
-
Anti-inflammatory property of the cannabinoid receptor-2-selective agonist JWH-133 in a rodent model of autoimmune uveoretinitis
-
Xu, H.; Cheng, C. L.; Chen, M.; Manivannan, A.; Cabay, L.; Pertwee, R. G.; Coutts, A.; Forrester, J. V. Anti-inflammatory property of the cannabinoid receptor-2-selective agonist JWH-133 in a rodent model of autoimmune uveoretinitis. J. Leukoc. Biol., 2007, 82, 532-541.
-
(2007)
J. Leukoc. Biol.
, vol.82
, pp. 532-541
-
-
Xu, H.1
Cheng, C.L.2
Chen, M.3
Manivannan, A.4
Cabay, L.5
Pertwee, R.G.6
Coutts, A.7
Forrester, J.V.8
-
89
-
-
34250717998
-
Cannabinoid CB(2) receptor activation decreases cerebral infarction in a mouse focal ischemia/reperfusion model
-
Zhang, M.; Martin, B. R.; Adler, M. W.; Razdan, R. K.; Jallo, J. I.; Tuma, R. F. Cannabinoid CB(2) receptor activation decreases cerebral infarction in a mouse focal ischemia/reperfusion model. J. Cereb. Blood Flow Metab., 2007, 27, 1387-1396.
-
(2007)
J. Cereb. Blood Flow Metab.
, vol.27
, pp. 1387-1396
-
-
Zhang, M.1
Martin, B.R.2
Adler, M.W.3
Razdan, R.K.4
Jallo, J.I.5
Tuma, R.F.6
-
90
-
-
33749261955
-
Targeting the CB2 receptor for immune modulation
-
Lunn, C. A.; Reich, E. P.; Bober, L. Targeting the CB2 receptor for immune modulation. Expert Opin. Ther. Targets, 2006, 10, 653-663.
-
(2006)
Expert Opin. Ther. Targets
, vol.10
, pp. 653-663
-
-
Lunn, C.A.1
Reich, E.P.2
Bober, L.3
-
91
-
-
61849125275
-
AM-251 and SR144528 are acyl CoA:Cholesterol acyltransferase inhibitors
-
Thewke D; Freeman-Anderson N; Pickle T; Netherland C; Chilton C. AM-251 and SR144528 are acyl CoA:cholesterol acyltransferase inhibitors. Biochem. Biophys. Res. Commun., 2009, 381, 181-186.
-
(2009)
Biochem. Biophys. Res. Commun.
, vol.381
, pp. 181-186
-
-
Thewke, D.1
Freeman-Anderson, N.2
Pickle, T.3
Netherland, C.4
Chilton, C.5
-
92
-
-
37149044115
-
Cannabinoid CB(2)-selective inverse agonist protects against antigeninduced bone loss
-
Lunn, C. A.; Fine, J.; Rojas-Triana, A.; Jackson, J. V.; Lavey, B.; Kozlowski, J. A.; Hipkin, R. W.; Lundell, D. J.; Bober, L. Cannabinoid CB(2)-selective inverse agonist protects against antigeninduced bone loss. Immunopharmacol. Immunotoxicol., 2007, 29, 387-401.
-
(2007)
Immunopharmacol. Immunotoxicol.
, vol.29
, pp. 387-401
-
-
Lunn, C.A.1
Fine, J.2
Rojas-Triana, A.3
Jackson, J.V.4
Lavey, B.5
Kozlowski, J.A.6
Hipkin, R.W.7
Lundell, D.J.8
Bober, L.9
-
93
-
-
54349124546
-
Regulation of bone mass, osteoclast function, and ovariectomy-induced bone loss by the type 2 cannabinoid receptor
-
Idris, A. I.; Sophocleous, A.; Landao-Bassonga, E.; van't Hof, R. J.; Ralston, S. H. Regulation of bone mass, osteoclast function, and ovariectomy-induced bone loss by the type 2 cannabinoid receptor. Endocrinology, 2008, 149, 5619-5626.
-
(2008)
Endocrinology
, vol.149
, pp. 5619-5626
-
-
Idris, A.I.1
Sophocleous, A.2
Landao-Bassonga, E.3
van't Hof, R.J.4
Ralston, S.H.5
-
94
-
-
57249087420
-
Activation of cannabinoid receptors prevents antigen-induced asthma-like reaction in guinea pigs
-
Giannini, L.; Nistri, S.; Mastroianni, R.; Cinci, L.; Vannacci, A.; Mariottini, C.; Passani, M. B.; Mannaioni, P. F.; Bani, D.; Masini, E. Activation of cannabinoid receptors prevents antigen-induced asthma-like reaction in guinea pigs. J. Cell. Mol. Med., 2008, 12, 2381-2394.
-
(2008)
J. Cell. Mol. Med.
, vol.12
, pp. 2381-2394
-
-
Giannini, L.1
Nistri, S.2
Mastroianni, R.3
Cinci, L.4
Vannacci, A.5
Mariottini, C.6
Passani, M.B.7
Mannaioni, P.F.8
Bani, D.9
Masini, E.10
-
95
-
-
34147165471
-
Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells
-
Maresz, K.; Pryce, G.; Ponomarev, E. D.; Marsicano, G.; Croxford, J. L.; Shriver, L. P.; Ledent, C.; Cheng, X.; Carrier, E. J.; Mann, M. K.; Giovannoni, G.; Pertwee, R. G.; Yamamura, T.; Buckley, N. E.; Hillard, C. J.; Lutz, B.; Baker, D.; Dittel, B. N. Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells. Nat. Med., 2007, 13, 492-497.
-
(2007)
Nat. Med.
, vol.13
, pp. 492-497
-
-
Maresz, K.1
Pryce, G.2
Ponomarev, E.D.3
Marsicano, G.4
Croxford, J.L.5
Shriver, L.P.6
Ledent, C.7
Cheng, X.8
Carrier, E.J.9
Mann, M.K.10
Giovannoni, G.11
Pertwee, R.G.12
Yamamura, T.13
Buckley, N.E.14
Hillard, C.J.15
Lutz, B.16
Baker, D.17
Dittel, B.N.18
-
96
-
-
45149123400
-
The CB(2) cannabinoid receptor controls myeloid progenitor trafficking: Involvement in the pathogenesis of an animal model of multiple sclerosis
-
Palazuelos, J.; Davoust, N.; Julien, B.; Hatterer, E.; Aguado, T.; Mechoulam, R.; Benito, C.; Romero, J.; Silva, A.; Guzmán, M.; Nataf, S.; Galve-Roperh, I. The CB(2) cannabinoid receptor controls myeloid progenitor trafficking: involvement in the pathogenesis of an animal model of multiple sclerosis. J. Biol. Chem., 2008, 283, 13320-13329.
-
(2008)
J. Biol. Chem.
, vol.283
, pp. 13320-13329
-
-
Palazuelos, J.1
Davoust, N.2
Julien, B.3
Hatterer, E.4
Aguado, T.5
Mechoulam, R.6
Benito, C.7
Romero, J.8
Silva, A.9
Guzmán, M.10
Nataf, S.11
Galve-Roperh, I.12
-
97
-
-
38349132542
-
Cannabinoid receptors and the regulation of bone mass
-
Bab, I.; Zimmer, A. Cannabinoid receptors and the regulation of bone mass. Br. J. Pharmacol., 2008, 153, 182-188.
-
(2008)
Br. J. Pharmacol.
, vol.153
, pp. 182-188
-
-
Bab, I.1
Zimmer, A.2
-
98
-
-
33845811458
-
Involvement of cannabinoid CB2 receptors in the IgE-mediated triphasic cutaneous reaction in mice
-
Ueda, Y.; Miyagawa, N.; Wakitani, K. Involvement of cannabinoid CB2 receptors in the IgE-mediated triphasic cutaneous reaction in mice. Life Sci., 2007, 80, 414-419.
-
(2007)
Life Sci
, vol.80
, pp. 414-419
-
-
Ueda, Y.1
Miyagawa, N.2
Wakitani, K.3
-
99
-
-
33745997333
-
The cannabinoid CB2 receptor inverse agonist JTE-907 suppresses spontaneous itch-associated responses of NC mice, a model of atopic dermatitis
-
Maekawa, T.; Nojima, H.; Kuraishi, Y.; Aisaka, K. The cannabinoid CB2 receptor inverse agonist JTE-907 suppresses spontaneous itch-associated responses of NC mice, a model of atopic dermatitis. Eur. J. Pharmacol., 2006, 542, 179-183.
-
(2006)
Eur. J. Pharmacol.
, vol.542
, pp. 179-183
-
-
Maekawa, T.1
Nojima, H.2
Kuraishi, Y.3
Aisaka, K.4
-
100
-
-
58249144544
-
Cannabidiol decreases bone resorption by inhibiting RANK/RANKL expression and pro-inflammatory cytokines during experimental periodontitis in rats
-
Napimoga, M. H.; Benatti, B. B.; Lima, F. O.; Alves, P. M.; Campos, A. C.; Pena-Dos-Santos, D. R.; Severino, F. P.; Cunha, F. Q.; Guimarães, F. S. Cannabidiol decreases bone resorption by inhibiting RANK/RANKL expression and pro-inflammatory cytokines during experimental periodontitis in rats. Int. Immunopharmacol., 2009, 9, 216-222.
-
(2009)
Int. Immunopharmacol.
, vol.9
, pp. 216-222
-
-
Napimoga, M.H.1
Benatti, B.B.2
Lima, F.O.3
Alves, P.M.4
Campos, A.C.5
Pena-Dos-Santos, D.R.6
Severino, F.P.7
Cunha, F.Q.8
Guimarães, F.S.9
-
101
-
-
33847653702
-
Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro
-
Thomas, A.; Baillie, G. L.; Phillips, A. M.; Razdan, R. K.; Ross, R. A.; Pertwee, R. G. Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro. Br. J. Pharmacol., 2007, 150, 613-623.
-
(2007)
Br. J. Pharmacol.
, vol.150
, pp. 613-623
-
-
Thomas, A.1
Baillie, G.L.2
Phillips, A.M.3
Razdan, R.K.4
Ross, R.A.5
Pertwee, R.G.6
-
102
-
-
34447642715
-
The evasive nature of drug efficacy: Implications for drug discovery
-
Galandrin, S.; Oligny-Longpré, G.; Bouvier, M. The evasive nature of drug efficacy: implications for drug discovery. Trends Pharmacol. Sci., 2007, 28, 423-430.
-
(2007)
Trends Pharmacol. Sci.
, vol.28
, pp. 423-430
-
-
Galandrin, S.1
Oligny-Longpré, G.2
Bouvier, M.3
|